Min Shi Lee

Summary

Country: China

Publications

  1. ncbi Measles IgG seroprevalence prior to mass vaccination in Taiwan
    Min Shi Lee
    National Institute of Preventive Medicine currently Center for Disease Control, Department of Health, Taiwan
    Int J Infect Dis 6:42-7. 2002
  2. ncbi Identifying potential immunodominant positions and predicting antigenic variants of influenza A/H3N2 viruses
    Min Shi Lee
    Vaccine R and D Center, National Health Research Institutes, Zhunan, Taiwan
    Vaccine 25:8133-9. 2007
  3. ncbi Half-life of human parainfluenza virus type 3 (hPIV3) maternal antibody and cumulative proportion of hPIV3 infection in young infants
    M S Lee
    Aviron, 297 N Bernardo Ave, Mountain View, CA 94043, USA
    J Infect Dis 183:1281-4. 2001
  4. ncbi Medical burden of respiratory syncytial virus and parainfluenza virus type 3 infection among US children. Implications for design of vaccine trials
    Min Shi Lee
    MedImmune Vaccines Inc, Mountain View, California, USA
    Hum Vaccin 1:6-11. 2005
  5. ncbi Predicting antigenic variants of influenza A/H3N2 viruses
    Min Shi Lee
    MedImmune Vaccines, Mountain View, California 94043, USA
    Emerg Infect Dis 10:1385-90. 2004
  6. ncbi Cross-reactive H1N1 antibody responses to a live attenuated influenza vaccine in children: implication for selection of vaccine strains
    Min Shi Lee
    MedImmune Vaccines, Mountain View, California 94043, USA
    J Infect Dis 188:1362-6. 2003
  7. ncbi Predicting and comparing long-term measles antibody profiles of different immunization policies
    M S Lee
    Wellcome Trust Centre for the Epidemiology of Infectious Disease, Oxford University, England
    Bull World Health Organ 79:615-24. 2001
  8. ncbi Antibody responses to bovine parainfluenza virus type 3 (PIV3) vaccination and human PIV3 infection in young infants
    M S Lee
    Aviron, Mountain View, CA 94043, USA
    J Infect Dis 184:909-13. 2001
  9. ncbi Two residues in the hemagglutinin of A/Fujian/411/02-like influenza viruses are responsible for antigenic drift from A/Panama/2007/99
    Hong Jin
    MedImmune Vaccines, Inc, 297 North Bernardo Avenue, Mountain View, CA 94043, USA
    Virology 336:113-9. 2005
  10. ncbi A bovine parainfluenza virus type 3 vaccine is safe and immunogenic in early infancy
    David P Greenberg
    University of Pittsburgh School of Medicine, Children s Hospital of Pittsburgh, Pittsburgh, Pennsylvania, USA
    J Infect Dis 191:1116-22. 2005

Detail Information

Publications16

  1. ncbi Measles IgG seroprevalence prior to mass vaccination in Taiwan
    Min Shi Lee
    National Institute of Preventive Medicine currently Center for Disease Control, Department of Health, Taiwan
    Int J Infect Dis 6:42-7. 2002
    ..Measles vaccine was licensed for use in Taiwan in 1968 and mass vaccination has been implemented since 1978. Serological surveys were conducted to characterize measles seroepidemiology prior to mass vaccination...
  2. ncbi Identifying potential immunodominant positions and predicting antigenic variants of influenza A/H3N2 viruses
    Min Shi Lee
    Vaccine R and D Center, National Health Research Institutes, Zhunan, Taiwan
    Vaccine 25:8133-9. 2007
    ..The model could be readily integrated to the global influenza surveillance system...
  3. ncbi Half-life of human parainfluenza virus type 3 (hPIV3) maternal antibody and cumulative proportion of hPIV3 infection in young infants
    M S Lee
    Aviron, 297 N Bernardo Ave, Mountain View, CA 94043, USA
    J Infect Dis 183:1281-4. 2001
    ....
  4. ncbi Medical burden of respiratory syncytial virus and parainfluenza virus type 3 infection among US children. Implications for design of vaccine trials
    Min Shi Lee
    MedImmune Vaccines Inc, Mountain View, California, USA
    Hum Vaccin 1:6-11. 2005
    ..Since age-specific rates of RSV and PIV3-related LRI can vary significantly in different populations, collecting age-specific LRI rates in phase 1 and 2 trials to further understand this variability appears warranted...
  5. ncbi Predicting antigenic variants of influenza A/H3N2 viruses
    Min Shi Lee
    MedImmune Vaccines, Mountain View, California 94043, USA
    Emerg Infect Dis 10:1385-90. 2004
    ..The methods described in this study could be applied to predict vaccine-induced cross-reactive antibody responses in humans, which may further improve the selection of vaccine strains...
  6. ncbi Cross-reactive H1N1 antibody responses to a live attenuated influenza vaccine in children: implication for selection of vaccine strains
    Min Shi Lee
    MedImmune Vaccines, Mountain View, California 94043, USA
    J Infect Dis 188:1362-6. 2003
    ..The observed differences in HAI cross-reactivity seem to be partly related to the number of amino acid (aa) differences on the hemagglutinin 1 domain (328 aa residues) rather than the hemagglutinin protein (550 aa residues)...
  7. ncbi Predicting and comparing long-term measles antibody profiles of different immunization policies
    M S Lee
    Wellcome Trust Centre for the Epidemiology of Infectious Disease, Oxford University, England
    Bull World Health Organ 79:615-24. 2001
    ..Epidemiological models are developed to predict the long-term measles antibody profiles and compare the merits of different immunization policies on the island...
  8. ncbi Antibody responses to bovine parainfluenza virus type 3 (PIV3) vaccination and human PIV3 infection in young infants
    M S Lee
    Aviron, Mountain View, CA 94043, USA
    J Infect Dis 184:909-13. 2001
    ....
  9. ncbi Two residues in the hemagglutinin of A/Fujian/411/02-like influenza viruses are responsible for antigenic drift from A/Panama/2007/99
    Hong Jin
    MedImmune Vaccines, Inc, 297 North Bernardo Avenue, Mountain View, CA 94043, USA
    Virology 336:113-9. 2005
    ....
  10. ncbi A bovine parainfluenza virus type 3 vaccine is safe and immunogenic in early infancy
    David P Greenberg
    University of Pittsburgh School of Medicine, Children s Hospital of Pittsburgh, Pittsburgh, Pennsylvania, USA
    J Infect Dis 191:1116-22. 2005
    ..A phase 2 trial was conducted to assess in young infants the safety, tolerability, infectivity, and immunogenicity of multiple doses of an intranasal vaccine using bovine parainfluenza virus type 3 (bPIV3)...
  11. ncbi Live attenuated influenza vaccine induces cross-reactive antibody responses in children against an a/Fujian/411/2002-like H3N2 antigenic variant strain
    Paul M Mendelman
    MedImmune Vaccines, Mountain View, CA, USA
    Pediatr Infect Dis J 23:1053-5. 2004
    ..Results indicated that the live vaccine induced higher antibody responses than the inactivated vaccine against the A/Panama and A/Fujian-like viruses...
  12. ncbi Measuring antibody responses to a live attenuated influenza vaccine in children
    Min-Shi Lee
    MedImmune Vaccines, Mountain View, CA, USA
    Pediatr Infect Dis J 23:852-6. 2004
    ..CONCLUSIONS: The neutralization assay was more sensitive than the HAI assay for measuring H1N1 antibody responses after vaccination of children with the LAIV and may provide a better correlate of clinical protection provided by the LAIV...
  13. ncbi Safety and immunogenicity of a live-attenuated influenza vaccine blended and filled at two manufacturing facilities
    Terry Nolan
    Clinical Epidemiology and Biostatistics Unit, Department of Paediatrics, University of Melbourne and Murdoch Children's Research Institute, Royal Children's Hospital, Melbourne, Vict, Australia
    Vaccine 21:1224-31. 2003
    ..The results indicate that CAIV-T blended and filled in the two facilities had equivalent profiles of safety and immunogenicity...
  14. ncbi Safety, immunogenicity and efficacy of intranasal, live attenuated influenza vaccine
    Robert Belshe
    Division of Infectious Diseases and Immunology, Saint Louis University, 3635 Vista Avenue FDT 8N, St Louis, MO 63110, USA
    Expert Rev Vaccines 3:643-54. 2004
    ..In the future it is expected that additional studies will support a broadening of the age range for use with the LAIV to prevent influenza in children and adults...
  15. ncbi Independence of Taiwan and scientific publication
    Min-Shi Lee
    Lancet 360:575; author reply 575-6. 2002
  16. ncbi Bioinformatics models for predicting antigenic variants of influenza A/H3N2 virus
    Yu Chieh Liao
    Division of Biostatistics and Bioinformatics, National Health Research Institutes, Zhunan 350, Taiwan
    Bioinformatics 24:505-12. 2008
    ..67%). Twenty amino acid positions identified in our model contribute significantly to antigenic difference and are potential immunodominant positions...